Renault Société Anonyme (RNL)
Euronext Paris · France · prices in EUR · close of 16 Oct 2026
Key indicators
| Last close | EUR 352.60 |
|---|---|
| 52-week range | 329.90 – 383.99 |
| Return, 1 month / 3 months | −3.5% / −4.8% |
| Return, 1 year / 3 years | −1.8% / +32.4% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 14.4% |
| Worst drawdown (1 year) | -7.2% |
| Average daily value traded | 0.09M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Renault Société Anonyme is a French automobile manufacturer based in Boulogne-Billancourt, near Paris. It designs, builds and markets passenger cars and light commercial vehicles, selling them under the Renault, Dacia and Alpine brands to retail customers and fleet buyers around the world. The company also supplies vehicle parts and related services through its dealer network and works closely with alliance partners on shared platforms and technologies. Its vehicles range from small city cars and family models to vans and electric cars.
On this site Renault Société Anonyme appears as a stock on the Euronext Paris (France), code RNL, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Renault Société Anonyme (RNL) trades on the Euronext Paris in France. It last closed at EUR 352.60 on 16 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 39 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.8% and over the last three months it fell 4.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -1.7% | ||
| From 52-week high | -7.2% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.8% | ||
| 6-month return | 1.6% | ||
| 12-month return, skipping the last month | 1.7% | ||
| Stability (higher is calmer) | 97 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 14.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -7.2% | ||
| Liquidity | 62 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.09M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.2% |
|---|---|
| 1 month | −3.5% |
| 3 months | −4.8% |
| 6 months | +1.6% |
| 1 year | −1.8% |
| 3 years | +32.4% |
| 5 years | −2.7% |
Signals
| 50-day / 200-day average | 367.93 / 358.87 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.09 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Oct 2023 | EUR 30.6592 |
| 24 Oct 2022 | EUR 18.2504 |
| 25 Oct 2021 | EUR 18.2504 |
| 26 Oct 2020 | EUR 32.1562 |
| 24 Oct 2019 | EUR 21.3945 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.